FDA inspection
Konsyl Pharmaceuticals Inc: FDA inspection ending Apr 11, 2006
FDA inspection 421393 · No Action Indicated (NAI) · Easton, MD
Key facts
| Inspection ID | 421393 |
|---|---|
| Firm | Konsyl Pharmaceuticals Inc |
| FEI number | 1119033 |
| Address | 29515 Canvasback Dr Ste B |
| City | Easton |
| State | MD |
| ZIP | 21601-7241 |
| Fiscal year | 2006 |
| Inspection end date | Apr 11, 2006 |
| Classification | No Action Indicated (NAI) |
| Project area | New Drug Evaluation |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data